#FORMAT=WebAnno TSV 3.2
#T_SP=webanno.custom.Diy_coref|
#T_RL=webanno.custom.Diy_coref_re|BT_webanno.custom.Diy_coref


#Text=[0038] Subsequently, drying is performed whereafter the coated implants can be directly used.
1-1	0-1	[	_	_	
1-2	1-5	0038	_	_	
1-3	5-6	]	_	_	
1-4	7-19	Subsequently	_	_	
1-5	19-20	,	_	_	
1-6	21-27	drying	_	_	
1-7	28-30	is	_	_	
1-8	31-40	performed	_	_	
1-9	41-51	whereafter	_	_	
1-10	52-55	the	_	_	
1-11	56-62	coated	_	_	
1-12	63-71	implants	_	_	
1-13	72-75	can	_	_	
1-14	76-78	be	_	_	
1-15	79-87	directly	_	_	
1-16	88-92	used	_	_	
1-17	92-93	.	_	_	

#Text=Optionally, also a heat treatment at temperatures of 100 to 1000.degree.
2-1	94-104	Optionally	_	_	
2-2	104-105	,	_	_	
2-3	106-110	also	_	_	
2-4	111-112	a	_	_	
2-5	113-117	heat	_	_	
2-6	118-127	treatment	_	_	
2-7	128-130	at	_	_	
2-8	131-143	temperatures	_	_	
2-9	144-146	of	_	_	
2-10	147-150	100	_	_	
2-11	151-153	to	_	_	
2-12	154-158	1000	_	_	
2-13	158-159	.	_	_	
2-14	159-165	degree	_	_	
2-15	165-166	.	_	_	

#Text=C. for about 0.1-3 hours, preferably 0.1-1 hour is carried out which can take place under an oxygen, nitrogen, argon or air atmosphere.
3-1	167-168	C	_	_	
3-2	168-169	.	_	_	
3-3	170-173	for	_	_	
3-4	174-179	about	_	_	
3-5	180-183	0.1	_	_	
3-6	183-184	-	_	_	
3-7	184-185	3	_	_	
3-8	186-191	hours	_	_	
3-9	191-192	,	_	_	
3-10	193-203	preferably	_	_	
3-11	204-207	0.1	_	_	
3-12	207-208	-	_	_	
3-13	208-209	1	_	_	
3-14	210-214	hour	_	_	
3-15	215-217	is	_	_	
3-16	218-225	carried	_	_	
3-17	226-229	out	_	_	
3-18	230-235	which	_	_	
3-19	236-239	can	_	_	
3-20	240-244	take	_	_	
3-21	245-250	place	_	_	
3-22	251-256	under	_	_	
3-23	257-259	an	_	_	
3-24	260-266	oxygen	_	_	
3-25	266-267	,	_	_	
3-26	268-276	nitrogen	_	_	
3-27	276-277	,	_	_	
3-28	278-283	argon	_	_	
3-29	284-286	or	_	_	
3-30	287-290	air	_	_	
3-31	291-301	atmosphere	_	_	
3-32	301-302	.	_	_	

#Text=This subsequent heat treatment serves for mechanical stabilization or densification, respectively, of the coatings.
4-1	303-307	This	_	_	
4-2	308-318	subsequent	_	_	
4-3	319-323	heat	_	_	
4-4	324-333	treatment	_	_	
4-5	334-340	serves	_	_	
4-6	341-344	for	_	_	
4-7	345-355	mechanical	_	_	
4-8	356-369	stabilization	_	_	
4-9	370-372	or	_	_	
4-10	373-386	densification	_	_	
4-11	386-387	,	_	_	
4-12	388-400	respectively	_	_	
4-13	400-401	,	_	_	
4-14	402-404	of	_	_	
4-15	405-408	the	_	_	
4-16	409-417	coatings	_	_	
4-17	417-418	.	_	_	

#Text=For example ceramization of the coating can be achieved preferably by heating at about 500.degree.
5-1	419-422	For	_	_	
5-2	423-430	example	_	_	
5-3	431-443	ceramization	_	_	
5-4	444-446	of	_	_	
5-5	447-450	the	_	_	
5-6	451-458	coating	_	_	
5-7	459-462	can	_	_	
5-8	463-465	be	_	_	
5-9	466-474	achieved	_	_	
5-10	475-485	preferably	_	_	
5-11	486-488	by	_	_	
5-12	489-496	heating	_	_	
5-13	497-499	at	_	_	
5-14	500-505	about	_	_	
5-15	506-509	500	_	_	
5-16	509-510	.	_	_	
5-17	510-516	degree	_	_	
5-18	516-517	.	_	_	

#Text=C.
6-1	518-519	C	_	_	
6-2	519-520	.	_	_	

#Text=In the case of plastic implants preferably heating at lower temperatures is carried out.
#Text=[0039] The drying step optionally is performed under supercritical conditions, preferably in an autoclave.
7-1	521-523	In	_	_	
7-2	524-527	the	_	_	
7-3	528-532	case	_	_	
7-4	533-535	of	_	_	
7-5	536-543	plastic	_	_	
7-6	544-552	implants	_	_	
7-7	553-563	preferably	_	_	
7-8	564-571	heating	_	_	
7-9	572-574	at	_	_	
7-10	575-580	lower	_	_	
7-11	581-593	temperatures	_	_	
7-12	594-596	is	_	_	
7-13	597-604	carried	_	_	
7-14	605-608	out	_	_	
7-15	608-609	.	_	_	
7-16	610-611	[	*[1]	8-68[2_1]	
7-17	611-615	0039	*[1]	_	
7-18	615-616	]	*[1]	_	
7-19	617-620	The	*[1]	_	
7-20	621-627	drying	*[1]	_	
7-21	628-632	step	*[1]	_	
7-22	633-643	optionally	*[1]	_	
7-23	644-646	is	*[1]	_	
7-24	647-656	performed	*[1]	_	
7-25	657-662	under	*[1]	_	
7-26	663-676	supercritical	*[1]	_	
7-27	677-687	conditions	*[1]	_	
7-28	687-688	,	*[1]	_	
7-29	689-699	preferably	*[1]	_	
7-30	700-702	in	*[1]	_	
7-31	703-705	an	*[1]	_	
7-32	706-715	autoclave	*[1]	_	
7-33	715-716	.	*[1]	_	

#Text="Supercritical conditions" as referred to herein is intended to mean a pressure-temperature-time profile at a predetermined autoclave volume wherein by means of reducing the specific density without formation of a phase boundary the solvent used is carried from the liquid into the gaseous state beyond the physically defined critical point and is thereby removed from the layer.
#Text=[0040] The specific advantages of this method are that the pore structure in the nanometer range which is typical for gels is retained whereby a very high specific surface of the coating is formed.
8-1	717-718	"	_	_	
8-2	718-731	Supercritical	_	_	
8-3	732-742	conditions	_	_	
8-4	742-743	"	_	_	
8-5	744-746	as	_	_	
8-6	747-755	referred	_	_	
8-7	756-758	to	_	_	
8-8	759-765	herein	_	_	
8-9	766-768	is	_	_	
8-10	769-777	intended	_	_	
8-11	778-780	to	_	_	
8-12	781-785	mean	_	_	
8-13	786-787	a	_	_	
8-14	788-813	pressure-temperature-time	_	_	
8-15	814-821	profile	_	_	
8-16	822-824	at	_	_	
8-17	825-826	a	_	_	
8-18	827-840	predetermined	_	_	
8-19	841-850	autoclave	_	_	
8-20	851-857	volume	_	_	
8-21	858-865	wherein	_	_	
8-22	866-868	by	_	_	
8-23	869-874	means	_	_	
8-24	875-877	of	_	_	
8-25	878-886	reducing	_	_	
8-26	887-890	the	_	_	
8-27	891-899	specific	_	_	
8-28	900-907	density	_	_	
8-29	908-915	without	_	_	
8-30	916-925	formation	_	_	
8-31	926-928	of	_	_	
8-32	929-930	a	_	_	
8-33	931-936	phase	_	_	
8-34	937-945	boundary	_	_	
8-35	946-949	the	_	_	
8-36	950-957	solvent	_	_	
8-37	958-962	used	_	_	
8-38	963-965	is	_	_	
8-39	966-973	carried	_	_	
8-40	974-978	from	_	_	
8-41	979-982	the	_	_	
8-42	983-989	liquid	_	_	
8-43	990-994	into	_	_	
8-44	995-998	the	_	_	
8-45	999-1006	gaseous	_	_	
8-46	1007-1012	state	_	_	
8-47	1013-1019	beyond	_	_	
8-48	1020-1023	the	_	_	
8-49	1024-1034	physically	_	_	
8-50	1035-1042	defined	_	_	
8-51	1043-1051	critical	_	_	
8-52	1052-1057	point	_	_	
8-53	1058-1061	and	_	_	
8-54	1062-1064	is	_	_	
8-55	1065-1072	thereby	_	_	
8-56	1073-1080	removed	_	_	
8-57	1081-1085	from	_	_	
8-58	1086-1089	the	_	_	
8-59	1090-1095	layer	_	_	
8-60	1095-1096	.	_	_	
8-61	1097-1098	[	_	_	
8-62	1098-1102	0040	_	_	
8-63	1102-1103	]	_	_	
8-64	1104-1107	The	_	_	
8-65	1108-1116	specific	_	_	
8-66	1117-1127	advantages	_	_	
8-67	1128-1130	of	_	_	
8-68	1131-1135	this	*[2]	_	
8-69	1136-1142	method	*[2]	_	
8-70	1143-1146	are	_	_	
8-71	1147-1151	that	_	_	
8-72	1152-1155	the	_	_	
8-73	1156-1160	pore	_	_	
8-74	1161-1170	structure	_	_	
8-75	1171-1173	in	_	_	
8-76	1174-1177	the	_	_	
8-77	1178-1187	nanometer	_	_	
8-78	1188-1193	range	_	_	
8-79	1194-1199	which	_	_	
8-80	1200-1202	is	_	_	
8-81	1203-1210	typical	_	_	
8-82	1211-1214	for	_	_	
8-83	1215-1219	gels	_	_	
8-84	1220-1222	is	_	_	
8-85	1223-1231	retained	_	_	
8-86	1232-1239	whereby	_	_	
8-87	1240-1241	a	_	_	
8-88	1242-1246	very	_	_	
8-89	1247-1251	high	_	_	
8-90	1252-1260	specific	_	_	
8-91	1261-1268	surface	_	_	
8-92	1269-1271	of	_	_	
8-93	1272-1275	the	_	_	
8-94	1276-1283	coating	_	_	
8-95	1284-1286	is	_	_	
8-96	1287-1293	formed	_	_	
8-97	1293-1294	.	_	_	

#Text=This allows on the one hand to exert an additional influence on the ion release kinetics of the copper ions and on the other hand, by creating a structured porous surface, to bring about a positive influence on the growth of body cells such as osteoblasts or fibroblasts.
#Text=[0041] Optionally, also a heat treatment at temperatures of 100 to 1000.degree.
9-1	1295-1299	This	_	_	
9-2	1300-1306	allows	_	_	
9-3	1307-1309	on	_	_	
9-4	1310-1313	the	_	_	
9-5	1314-1317	one	_	_	
9-6	1318-1322	hand	_	_	
9-7	1323-1325	to	_	_	
9-8	1326-1331	exert	_	_	
9-9	1332-1334	an	_	_	
9-10	1335-1345	additional	_	_	
9-11	1346-1355	influence	_	_	
9-12	1356-1358	on	_	_	
9-13	1359-1362	the	_	_	
9-14	1363-1366	ion	_	_	
9-15	1367-1374	release	_	_	
9-16	1375-1383	kinetics	_	_	
9-17	1384-1386	of	_	_	
9-18	1387-1390	the	_	_	
9-19	1391-1397	copper	_	_	
9-20	1398-1402	ions	_	_	
9-21	1403-1406	and	_	_	
9-22	1407-1409	on	_	_	
9-23	1410-1413	the	_	_	
9-24	1414-1419	other	_	_	
9-25	1420-1424	hand	_	_	
9-26	1424-1425	,	_	_	
9-27	1426-1428	by	_	_	
9-28	1429-1437	creating	_	_	
9-29	1438-1439	a	_	_	
9-30	1440-1450	structured	_	_	
9-31	1451-1457	porous	_	_	
9-32	1458-1465	surface	_	_	
9-33	1465-1466	,	_	_	
9-34	1467-1469	to	_	_	
9-35	1470-1475	bring	_	_	
9-36	1476-1481	about	_	_	
9-37	1482-1483	a	_	_	
9-38	1484-1492	positive	_	_	
9-39	1493-1502	influence	_	_	
9-40	1503-1505	on	_	_	
9-41	1506-1509	the	_	_	
9-42	1510-1516	growth	_	_	
9-43	1517-1519	of	_	_	
9-44	1520-1524	body	_	_	
9-45	1525-1530	cells	_	_	
9-46	1531-1535	such	_	_	
9-47	1536-1538	as	_	_	
9-48	1539-1550	osteoblasts	_	_	
9-49	1551-1553	or	_	_	
9-50	1554-1565	fibroblasts	_	_	
9-51	1565-1566	.	_	_	
9-52	1567-1568	[	_	_	
9-53	1568-1572	0041	_	_	
9-54	1572-1573	]	_	_	
9-55	1574-1584	Optionally	_	_	
9-56	1584-1585	,	_	_	
9-57	1586-1590	also	_	_	
9-58	1591-1592	a	_	_	
9-59	1593-1597	heat	_	_	
9-60	1598-1607	treatment	_	_	
9-61	1608-1610	at	_	_	
9-62	1611-1623	temperatures	_	_	
9-63	1624-1626	of	_	_	
9-64	1627-1630	100	_	_	
9-65	1631-1633	to	_	_	
9-66	1634-1638	1000	_	_	
9-67	1638-1639	.	_	_	
9-68	1639-1645	degree	_	_	
9-69	1645-1646	.	_	_	

#Text=C. for about 0.1-3 hours, preferably 0.1-1 hour is carried out which can take place under an oxygen, nitrogen, argon or air atmosphere.
10-1	1647-1648	C	_	_	
10-2	1648-1649	.	_	_	
10-3	1650-1653	for	_	_	
10-4	1654-1659	about	_	_	
10-5	1660-1663	0.1	_	_	
10-6	1663-1664	-	_	_	
10-7	1664-1665	3	_	_	
10-8	1666-1671	hours	_	_	
10-9	1671-1672	,	_	_	
10-10	1673-1683	preferably	_	_	
10-11	1684-1687	0.1	_	_	
10-12	1687-1688	-	_	_	
10-13	1688-1689	1	_	_	
10-14	1690-1694	hour	_	_	
10-15	1695-1697	is	_	_	
10-16	1698-1705	carried	_	_	
10-17	1706-1709	out	_	_	
10-18	1710-1715	which	_	_	
10-19	1716-1719	can	_	_	
10-20	1720-1724	take	_	_	
10-21	1725-1730	place	_	_	
10-22	1731-1736	under	_	_	
10-23	1737-1739	an	_	_	
10-24	1740-1746	oxygen	_	_	
10-25	1746-1747	,	_	_	
10-26	1748-1756	nitrogen	_	_	
10-27	1756-1757	,	_	_	
10-28	1758-1763	argon	_	_	
10-29	1764-1766	or	_	_	
10-30	1767-1770	air	_	_	
10-31	1771-1781	atmosphere	_	_	
10-32	1781-1782	.	_	_	

#Text=This subsequent heat treatment serves for mechanical stabilization of the coatings.
11-1	1783-1787	This	_	_	
11-2	1788-1798	subsequent	_	_	
11-3	1799-1803	heat	_	_	
11-4	1804-1813	treatment	_	_	
11-5	1814-1820	serves	_	_	
11-6	1821-1824	for	_	_	
11-7	1825-1835	mechanical	_	_	
11-8	1836-1849	stabilization	_	_	
11-9	1850-1852	of	_	_	
11-10	1853-1856	the	_	_	
11-11	1857-1865	coatings	_	_	
11-12	1865-1866	.	_	_	

#Text=For example ceramization of the coating can be preferably achieved by heating at about 500.degree.
12-1	1867-1870	For	_	_	
12-2	1871-1878	example	_	_	
12-3	1879-1891	ceramization	_	_	
12-4	1892-1894	of	_	_	
12-5	1895-1898	the	_	_	
12-6	1899-1906	coating	_	_	
12-7	1907-1910	can	_	_	
12-8	1911-1913	be	_	_	
12-9	1914-1924	preferably	_	_	
12-10	1925-1933	achieved	_	_	
12-11	1934-1936	by	_	_	
12-12	1937-1944	heating	_	_	
12-13	1945-1947	at	_	_	
12-14	1948-1953	about	_	_	
12-15	1954-1957	500	_	_	
12-16	1957-1958	.	_	_	
12-17	1958-1964	degree	_	_	
12-18	1964-1965	.	_	_	

#Text=C.
13-1	1966-1967	C	_	_	
13-2	1967-1968	.	_	_	

#Text=In the case of plastic implants preferably heating at lower temperatures is carried out.
#Text=[0042] By means of the method according to the invention it is possible by dilution or multiple coating, respectively, to precisely adjust the concentration of metal ions, preferably copper and/or silver ions, in the coating.
14-1	1969-1971	In	_	_	
14-2	1972-1975	the	_	_	
14-3	1976-1980	case	_	_	
14-4	1981-1983	of	_	_	
14-5	1984-1991	plastic	_	_	
14-6	1992-2000	implants	_	_	
14-7	2001-2011	preferably	_	_	
14-8	2012-2019	heating	_	_	
14-9	2020-2022	at	_	_	
14-10	2023-2028	lower	_	_	
14-11	2029-2041	temperatures	_	_	
14-12	2042-2044	is	_	_	
14-13	2045-2052	carried	_	_	
14-14	2053-2056	out	_	_	
14-15	2056-2057	.	_	_	
14-16	2058-2059	[	_	_	
14-17	2059-2063	0042	_	_	
14-18	2063-2064	]	_	_	
14-19	2065-2067	By	_	_	
14-20	2068-2073	means	_	_	
14-21	2074-2076	of	_	_	
14-22	2077-2080	the	_	_	
14-23	2081-2087	method	_	_	
14-24	2088-2097	according	_	_	
14-25	2098-2100	to	_	_	
14-26	2101-2104	the	_	_	
14-27	2105-2114	invention	_	_	
14-28	2115-2117	it	_	_	
14-29	2118-2120	is	_	_	
14-30	2121-2129	possible	_	_	
14-31	2130-2132	by	_	_	
14-32	2133-2141	dilution	_	_	
14-33	2142-2144	or	_	_	
14-34	2145-2153	multiple	_	_	
14-35	2154-2161	coating	_	_	
14-36	2161-2162	,	_	_	
14-37	2163-2175	respectively	_	_	
14-38	2175-2176	,	_	_	
14-39	2177-2179	to	_	_	
14-40	2180-2189	precisely	_	_	
14-41	2190-2196	adjust	_	_	
14-42	2197-2200	the	_	_	
14-43	2201-2214	concentration	_	_	
14-44	2215-2217	of	_	_	
14-45	2218-2223	metal	_	_	
14-46	2224-2228	ions	_	_	
14-47	2228-2229	,	_	_	
14-48	2230-2240	preferably	_	_	
14-49	2241-2247	copper	_	_	
14-50	2248-2251	and	_	_	
14-51	2251-2252	/	_	_	
14-52	2252-2254	or	_	_	
14-53	2255-2261	silver	_	_	
14-54	2262-2266	ions	_	_	
14-55	2266-2267	,	_	_	
14-56	2268-2270	in	_	_	
14-57	2271-2274	the	_	_	
14-58	2275-2282	coating	_	_	
14-59	2282-2283	.	_	_	

#Text=By multiple coatings the anti-microbial effect of the coating can be enhanced since in this case a higher amount of metal ions having an anti-bacterial effect which can be eluted can be provided.
15-1	2284-2286	By	_	_	
15-2	2287-2295	multiple	_	_	
15-3	2296-2304	coatings	_	_	
15-4	2305-2308	the	_	_	
15-5	2309-2323	anti-microbial	_	_	
15-6	2324-2330	effect	_	_	
15-7	2331-2333	of	_	_	
15-8	2334-2337	the	_	_	
15-9	2338-2345	coating	_	_	
15-10	2346-2349	can	_	_	
15-11	2350-2352	be	_	_	
15-12	2353-2361	enhanced	_	_	
15-13	2362-2367	since	_	_	
15-14	2368-2370	in	_	_	
15-15	2371-2375	this	_	_	
15-16	2376-2380	case	_	_	
15-17	2381-2382	a	_	_	
15-18	2383-2389	higher	_	_	
15-19	2390-2396	amount	_	_	
15-20	2397-2399	of	_	_	
15-21	2400-2405	metal	_	_	
15-22	2406-2410	ions	_	_	
15-23	2411-2417	having	_	_	
15-24	2418-2420	an	_	_	
15-25	2421-2435	anti-bacterial	_	_	
15-26	2436-2442	effect	_	_	
15-27	2443-2448	which	_	_	
15-28	2449-2452	can	_	_	
15-29	2453-2455	be	_	_	
15-30	2456-2462	eluted	_	_	
15-31	2463-2466	can	_	_	
15-32	2467-2469	be	_	_	
15-33	2470-2478	provided	_	_	
15-34	2478-2479	.	_	_	

#Text=A double to fourfold coating is preferred.
16-1	2480-2481	A	_	_	
16-2	2482-2488	double	_	_	
16-3	2489-2491	to	_	_	
16-4	2492-2500	fourfold	_	_	
16-5	2501-2508	coating	_	_	
16-6	2509-2511	is	_	_	
16-7	2512-2521	preferred	_	_	
16-8	2521-2522	.	_	_	

#Text=According to the invention a multiple coating is prepared by repeating the steps of the preparation of a titanium oxide coating on an implant, i.e. addition of a preparation containing an organic solvent and an organometallic titanium oxide precursor and optionally water and/or an acid with metal salts and/or organometallic compounds to distribute metal ions homogeneously in the preparation, application of the preparation thus prepared onto an implant and drying the applied coating, once or more times so that one or more additional titanium oxide coatings are prepared on the implant.
17-1	2523-2532	According	_	_	
17-2	2533-2535	to	_	_	
17-3	2536-2539	the	_	_	
17-4	2540-2549	invention	_	_	
17-5	2550-2551	a	_	_	
17-6	2552-2560	multiple	_	_	
17-7	2561-2568	coating	_	_	
17-8	2569-2571	is	_	_	
17-9	2572-2580	prepared	_	_	
17-10	2581-2583	by	_	_	
17-11	2584-2593	repeating	_	_	
17-12	2594-2597	the	_	_	
17-13	2598-2603	steps	_	_	
17-14	2604-2606	of	_	_	
17-15	2607-2610	the	_	_	
17-16	2611-2622	preparation	_	_	
17-17	2623-2625	of	_	_	
17-18	2626-2627	a	_	_	
17-19	2628-2636	titanium	_	_	
17-20	2637-2642	oxide	_	_	
17-21	2643-2650	coating	_	_	
17-22	2651-2653	on	_	_	
17-23	2654-2656	an	_	_	
17-24	2657-2664	implant	_	_	
17-25	2664-2665	,	_	_	
17-26	2666-2669	i.e	_	_	
17-27	2669-2670	.	_	_	
17-28	2671-2679	addition	_	_	
17-29	2680-2682	of	_	_	
17-30	2683-2684	a	_	_	
17-31	2685-2696	preparation	_	_	
17-32	2697-2707	containing	_	_	
17-33	2708-2710	an	_	_	
17-34	2711-2718	organic	_	_	
17-35	2719-2726	solvent	_	_	
17-36	2727-2730	and	_	_	
17-37	2731-2733	an	_	_	
17-38	2734-2748	organometallic	_	_	
17-39	2749-2757	titanium	_	_	
17-40	2758-2763	oxide	_	_	
17-41	2764-2773	precursor	_	_	
17-42	2774-2777	and	_	_	
17-43	2778-2788	optionally	_	_	
17-44	2789-2794	water	_	_	
17-45	2795-2798	and	_	_	
17-46	2798-2799	/	_	_	
17-47	2799-2801	or	_	_	
17-48	2802-2804	an	_	_	
17-49	2805-2809	acid	_	_	
17-50	2810-2814	with	_	_	
17-51	2815-2820	metal	_	_	
17-52	2821-2826	salts	_	_	
17-53	2827-2830	and	_	_	
17-54	2830-2831	/	_	_	
17-55	2831-2833	or	_	_	
17-56	2834-2848	organometallic	_	_	
17-57	2849-2858	compounds	_	_	
17-58	2859-2861	to	_	_	
17-59	2862-2872	distribute	_	_	
17-60	2873-2878	metal	_	_	
17-61	2879-2883	ions	_	_	
17-62	2884-2897	homogeneously	_	_	
17-63	2898-2900	in	_	_	
17-64	2901-2904	the	_	_	
17-65	2905-2916	preparation	_	_	
17-66	2916-2917	,	_	_	
17-67	2918-2929	application	_	_	
17-68	2930-2932	of	_	_	
17-69	2933-2936	the	_	_	
17-70	2937-2948	preparation	_	_	
17-71	2949-2953	thus	_	_	
17-72	2954-2962	prepared	_	_	
17-73	2963-2967	onto	_	_	
17-74	2968-2970	an	_	_	
17-75	2971-2978	implant	_	_	
17-76	2979-2982	and	_	_	
17-77	2983-2989	drying	_	_	
17-78	2990-2993	the	_	_	
17-79	2994-3001	applied	_	_	
17-80	3002-3009	coating	_	_	
17-81	3009-3010	,	_	_	
17-82	3011-3015	once	_	_	
17-83	3016-3018	or	_	_	
17-84	3019-3023	more	_	_	
17-85	3024-3029	times	_	_	
17-86	3030-3032	so	_	_	
17-87	3033-3037	that	_	_	
17-88	3038-3041	one	_	_	
17-89	3042-3044	or	_	_	
17-90	3045-3049	more	_	_	
17-91	3050-3060	additional	_	_	
17-92	3061-3069	titanium	_	_	
17-93	3070-3075	oxide	_	_	
17-94	3076-3084	coatings	_	_	
17-95	3085-3088	are	_	_	
17-96	3089-3097	prepared	_	_	
17-97	3098-3100	on	_	_	
17-98	3101-3104	the	_	_	
17-99	3105-3112	implant	_	_	
17-100	3112-3113	.	_	_	

#Text=Optionally, heating to 100 to 1000.degree.
18-1	3114-3124	Optionally	_	_	
18-2	3124-3125	,	_	_	
18-3	3126-3133	heating	_	_	
18-4	3134-3136	to	_	_	
18-5	3137-3140	100	_	_	
18-6	3141-3143	to	_	_	
18-7	3144-3148	1000	_	_	
18-8	3148-3149	.	_	_	
18-9	3149-3155	degree	_	_	
18-10	3155-3156	.	_	_	

#Text=C. can be performed each time after the above-mentioned steps of the procedure have been carried out.
19-1	3157-3158	C	_	_	
19-2	3158-3159	.	_	_	
19-3	3160-3163	can	_	_	
19-4	3164-3166	be	_	_	
19-5	3167-3176	performed	_	_	
19-6	3177-3181	each	_	_	
19-7	3182-3186	time	_	_	
19-8	3187-3192	after	_	_	
19-9	3193-3196	the	_	_	
19-10	3197-3212	above-mentioned	_	_	
19-11	3213-3218	steps	_	_	
19-12	3219-3221	of	_	_	
19-13	3222-3225	the	_	_	
19-14	3226-3235	procedure	_	_	
19-15	3236-3240	have	_	_	
19-16	3241-3245	been	_	_	
19-17	3246-3253	carried	_	_	
19-18	3254-3257	out	_	_	
19-19	3257-3258	.	_	_	
